Proteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten®

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Proteotype-Platform

More Like This

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

PR Newswire associated0

Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

PR Newswire associated0

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

PR Newswire associated0

Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

PR Newswire associated0

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease.

Tres Alchemix Co. Ltd.

Tres Alchemix Closes $4.4 Million Series A To Advance AI Drug-Design Platform

PR Newswire associated0

Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer Early-Detection Test with Predictive Treatment Insights

PR Newswire associated0

Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)